位置:首页 > 蛋白库 > PGR1A_MOUSE
PGR1A_MOUSE
ID   PGR1A_MOUSE             Reviewed;         253 AA.
AC   Q99L02;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 124.
DE   RecName: Full=PAXIP1-associated glutamate-rich protein 1A {ECO:0000312|MGI:MGI:1914528};
DE   AltName: Full=PAXIP1-associated protein 1;
DE   AltName: Full=PTIP-associated protein 1;
GN   Name=Pagr1a {ECO:0000312|MGI:MGI:1914528};
GN   Synonyms=Pa1 {ECO:0000312|MGI:MGI:1914528}, Pagr;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH PAXIP1.
RX   PubMed=19124460; DOI=10.1074/jbc.m809158200;
RA   Gong Z., Cho Y.-W., Kim J.-E., Ge K., Chen J.;
RT   "Accumulation of Pax2 transactivation domain interaction protein (PTIP) at
RT   sites of DNA breaks via RNF8-dependent pathway is required for cell
RT   survival after DNA damage.";
RL   J. Biol. Chem. 284:7284-7293(2009).
RN   [4]
RP   TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE, AND
RP   FUNCTION.
RX   PubMed=24633704; DOI=10.1002/dvdy.24125;
RA   Kumar A., Lualdi M., Loncarek J., Cho Y.W., Lee J.E., Ge K., Kuehn M.R.;
RT   "Loss of function of mouse Pax-Interacting Protein 1-associated glutamate
RT   rich protein 1a (Pagr1a) leads to reduced Bmp2 expression and defects in
RT   chorion and amnion development.";
RL   Dev. Dyn. 243:937-947(2014).
RN   [5]
RP   FUNCTION, INTERACTION WITH PAXIP1, AND SUBCELLULAR LOCATION.
RX   PubMed=26744420; DOI=10.1101/gad.268797.115;
RA   Starnes L.M., Su D., Pikkupeura L.M., Weinert B.T., Santos M.A., Mund A.,
RA   Soria R., Cho Y.W., Pozdnyakova I., Kubec Hoejfeldt M., Vala A., Yang W.,
RA   Lopez-Mendez B., Lee J.E., Peng W., Yuan J., Ge K., Montoya G.,
RA   Nussenzweig A., Choudhary C., Daniel J.A.;
RT   "A PTIP-PA1 subcomplex promotes transcription for IgH class switching
RT   independently from the associated MLL3/MLL4 methyltransferase complex.";
RL   Genes Dev. 30:149-163(2016).
CC   -!- FUNCTION: Its association with the histone methyltransferase MLL2/MLL3
CC       complex is suggesting a role in epigenetic transcriptional activation.
CC       However, in association with PAXIP1/PTIP is proposed to function at
CC       least in part independently of the MLL2/MLL3 complex. Proposed to be
CC       recruited by PAXIP1 to sites of DNA damage where the PAGR1:PAXIP1
CC       complex is required for cell survival in response to DNA damage
CC       independently of the MLL2/MLL3 complex (PubMed:19124460). However, its
CC       function in DNA damage has been questioned (PubMed:26744420). During
CC       immunoglobulin class switching in activated B-cells is involved in
CC       transcription regulation of downstream switch regions at the
CC       immunoglobulin heavy-chain (Igh) locus independently of the MLL2/MLL3
CC       complex (PubMed:26744420). Involved in both estrogen receptor-regulated
CC       gene transcription and estrogen-stimulated G1/S cell-cycle transition
CC       (By similarity). Acts as transcriptional cofactor for nuclear hormone
CC       receptors. Inhibits the induction properties of several steroid
CC       receptors such as NR3C1, AR and PPARG; the mechanism of inhibition
CC       appears to be gene-dependent (By similarity). May be involved in the
CC       regulation of the BMP pathway in extraembryonic development
CC       (PubMed:24633704). {ECO:0000250|UniProtKB:Q9BTK6,
CC       ECO:0000269|PubMed:19124460, ECO:0000269|PubMed:26744420, ECO:0000305,
CC       ECO:0000305|PubMed:24633704}.
CC   -!- SUBUNIT: Component of the KMT2 family MLL2/MLL3 complex, at least
CC       composed of the histone methyltransferases KMT2D and/or KMT2C, the
CC       common subunits ASH2L, RBBP5, WDR5 and DPY30, and the complex type-
CC       specific subunits PAXIP1/PTIP, PAGR1, NCOA6 and KDM6A; PAXIP1 is
CC       required for the association with the MLL2/MLL3 complex (By
CC       similarity). Forms a constitutive complex with PAXIP1/PTIP
CC       independently of the MLL2/MLL3 complex (PubMed:19124460,
CC       PubMed:26744420). Interacts with NCOA1, ESR1, NR3C1, AR (By
CC       similarity). {ECO:0000250|UniProtKB:Q9BTK6,
CC       ECO:0000269|PubMed:19124460, ECO:0000269|PubMed:26744420}.
CC   -!- INTERACTION:
CC       Q99L02; Q6NZQ4: Paxip1; NbExp=11; IntAct=EBI-11667455, EBI-1395317;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26744420}.
CC   -!- DEVELOPMENTAL STAGE: Expression first detected at 5.0-6.0 dpc in the
CC       extraembryonic region, at 7.5 dpc detected within the chorion; later
CC       the expression is expanding to the entire embryo.
CC       {ECO:0000269|PubMed:24633704}.
CC   -!- DISRUPTION PHENOTYPE: Normal germ layer specification and developmental
CC       patterning but limited anterior development and arrest by 8.5 dpc,
CC       likely due at least in part to defects in extraembryonic tissue.
CC       {ECO:0000269|PubMed:24633704}.
CC   -!- CAUTION: The terminology of MLL proteins in mammalia is not consistent
CC       also concerning the terminology of MLL protein-containing complexes.
CC       The decribed MLL2/MLL3 complex is commonly described as MLL3/MLL4
CC       complex in literature. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK082775; BAC38614.1; -; mRNA.
DR   EMBL; BC003932; AAH03932.1; -; mRNA.
DR   CCDS; CCDS21854.1; -.
DR   RefSeq; NP_084516.1; NM_030240.1.
DR   AlphaFoldDB; Q99L02; -.
DR   BioGRID; 212067; 3.
DR   IntAct; Q99L02; 1.
DR   STRING; 10090.ENSMUSP00000032918; -.
DR   iPTMnet; Q99L02; -.
DR   PhosphoSitePlus; Q99L02; -.
DR   EPD; Q99L02; -.
DR   jPOST; Q99L02; -.
DR   MaxQB; Q99L02; -.
DR   PaxDb; Q99L02; -.
DR   PeptideAtlas; Q99L02; -.
DR   PRIDE; Q99L02; -.
DR   DNASU; 67278; -.
DR   Ensembl; ENSMUST00000200948; ENSMUSP00000144469; ENSMUSG00000030680.
DR   Ensembl; ENSMUST00000202798; ENSMUSP00000144243; ENSMUSG00000107068.
DR   GeneID; 67278; -.
DR   KEGG; mmu:67278; -.
DR   UCSC; uc009jtx.1; mouse.
DR   CTD; 67278; -.
DR   MGI; MGI:1914528; Pagr1a.
DR   VEuPathDB; HostDB:ENSMUSG00000030680; -.
DR   VEuPathDB; HostDB:ENSMUSG00000107068; -.
DR   eggNOG; ENOG502S0T8; Eukaryota.
DR   GeneTree; ENSGT00390000016049; -.
DR   HOGENOM; CLU_088613_1_0_1; -.
DR   InParanoid; Q99L02; -.
DR   OMA; QAWMPPP; -.
DR   OrthoDB; 1630689at2759; -.
DR   PhylomeDB; Q99L02; -.
DR   TreeFam; TF326621; -.
DR   BioGRID-ORCS; 67278; 8 hits in 77 CRISPR screens.
DR   ChiTaRS; Pagr1a; mouse.
DR   PRO; PR:Q99L02; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q99L02; protein.
DR   Bgee; ENSMUSG00000030680; Expressed in cerebellar cortex and 63 other tissues.
DR   ExpressionAtlas; Q99L02; baseline and differential.
DR   Genevisible; Q99L02; MM.
DR   GO; GO:0035097; C:histone methyltransferase complex; IDA:MGI.
DR   GO; GO:0044666; C:MLL3/4 complex; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; ISO:MGI.
DR   GO; GO:0060717; P:chorion development; IMP:MGI.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0071557; P:histone H3-K27 demethylation; IDA:MGI.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IBA:GO_Central.
DR   GO; GO:1902808; P:positive regulation of cell cycle G1/S phase transition; ISO:MGI.
DR   GO; GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; ISO:MGI.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IMP:UniProtKB.
DR   GO; GO:2001022; P:positive regulation of response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:1902749; P:regulation of cell cycle G2/M phase transition; IMP:UniProtKB.
DR   InterPro; IPR028213; PA1.
DR   PANTHER; PTHR28467; PTHR28467; 1.
DR   Pfam; PF15364; PAXIP1_C; 1.
PE   1: Evidence at protein level;
KW   DNA damage; DNA recombination; DNA repair; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN           1..253
FT                   /note="PAXIP1-associated glutamate-rich protein 1A"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000248335"
FT   REGION          1..108
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          115..159
FT                   /note="Sufficient for interaction with NCOA1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTK6"
FT   REGION          126..253
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          160..253
FT                   /note="Sufficient for interaction with ESR1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTK6"
FT   COMPBIAS        48..85
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        156..221
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        229..253
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         137
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5M865"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5M865"
FT   MOD_RES         147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5M865"
FT   MOD_RES         236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5M865"
SQ   SEQUENCE   253 AA;  27723 MW;  AA5E4C4503A5C6FF CRC64;
     MSLALGHGTI AGSTAAPLSE EGEVTSGLQA LAVEDTGGPS VSASKAEEEG KGSQEEAGRE
     GSRPEEALEA PSAASDERAE GEAEDWCVPC SDEEVELPAN GQSWMPPPSE IQRLYELLAT
     QGTLELQAEI LPRRPPTPEA QSEEERSDEE PEAKEEEEEK PHMPTEFDFD DEPMTPKDSL
     IDRRRTPGSS ARSQKREARL DKVLSDMKRH KKLEEQILRT GRDLFSLDSE GPSPTSPPLR
     SSGNSLFPRQ RKY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024